Watch CBS News



Using weight-loss drugs before pregnancy

Doctors are seeing more women turn to weight-loss drugs ahead of pregnancy. Studies show that being overweight can increase the chances of pregnancy complications, including miscarriages. And while the FDA does not authorize the use of weight loss medications during pregnancy, there is limited information on their effects before conception. Dr. Ilana Ramer Bass, an assistant professor in the division of endocrinology, diabetes and metabolism at Mount Sinai, joined CBS News to discuss the trend.


How Ozempic, other weight-loss drugs are "changing medicine"

Ozempic and other GLP-1 class medications are being proven beneficial for reducing cardiovascular risk and treating diabetes. But they also signal fullness to the brain and regulate blood sugar, allowing people to lose on average 10 to 20 percent of their body weight in the first year. For many of the roughly 74 percent of Americans who are overweight or obese, that's almost unimaginable. Correspondent Susan Spencer talks with doctors and patients about how these drugs work, and why they are considered life-changing (and even, for Wall Street analysts, a miracle).


Companies work on products for Ozempic users

Food companies are trying to capitalize on the popular weight-loss drug Ozempic. According to new reporting from The Wall Street Journal, companies like Nestle and General Mills are working on products to pitch as natural alternatives or companion products for people taking Ozempic to use in addition to the weight loss drug. Jesse Newman, a reporter for The Wall Street Journal covering food and agriculture, joined CBS News to discuss the trend.


Doctors see demand for weight-loss drugs

Doctors across the country are dealing with soaring demand for injectable weight-loss drugs, especially among people who are not clinically obese. Drugs like Ozempic and Wegovy have proved to be especially effective for weight loss, but some health experts are worried their increased use could potentially be harmful to certain patients. Dr. Shauna Levy, medical director of Tulane's Bariatric and Weight Loss Center, joined CBS News to discuss the medications.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.